THE POTENTIAL OF MORINGA OLEIFERA LAM. LEAVES AS AN ANTIOXIDANT AND ITS FORMULATION AND CHARACTERIZATION AS A NANOSTRUCTURED LIPID CARRIER

The skin is a protective organ of the body with an important aesthetic role. Continuous exposure of the skin to direct ultraviolet (UV) radiation from the sun and environmental pollutants can trigger the excessive formation of reactive oxygen species (ROS) within the body. The generation of RO...

Full description

Saved in:
Bibliographic Details
Main Author: Permata Putri, Nidenia
Format: Final Project
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/76571
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
Description
Summary:The skin is a protective organ of the body with an important aesthetic role. Continuous exposure of the skin to direct ultraviolet (UV) radiation from the sun and environmental pollutants can trigger the excessive formation of reactive oxygen species (ROS) within the body. The generation of ROS on the skin can lead to oxidative stress and is believed to contribute to skin aging due to UV radiation. Moringa oleifera Lam. is one of the plants that contains various types of antioxidant compounds that are useful for preventing skin aging caused by UV exposure. This research aims to determine the antioxidant activity of ethanol extract and fractions from moringa leaves, as well as to formulate and characterize nanostructured lipid carriers (NLC) from the selected part of moringa leaves with the best antioxidant activity. Extraction was carried out using the maceration method with 96% ethanol as the solvent. Fractionation was done using liquid-liquid extraction with n-hexane, ethyl acetate, and water as solvents. Antioxidant activity tests on the extract and fractions were conducted using TLC-Bioautography and determination of IC50 values using the DPPH method. The IC50 values for the extract, n-hexane fraction, ethyl acetate fraction, and aqueous-ethanol fraction were 199.79 ± 1.89, 194.96 ± 0.52, 85.77 ± 1.04, and 155.93 ± 2.51 ?g/mL, respectively. The ethyl acetate fraction was chosen as the active ingredient for further preparation of NLC due to its best antioxidant activity. Optimization of the NLC formulation included screening of lipids, optimization of lipid ratio, co-surfactant screening, and total surfactant concentration optimization. The obtained optimal formula consisted of 0.5% ethyl acetate fraction of moringa leaves, 1.8% glyceryl monostearate, 4.2% oleic acid, 4% Tween 80, and 1% TEGO® Care 165. The resulting NLC had a particle size of 253.63 ± 4.97 nm, polydispersity index of 0.34 ± 0.06, zeta potential of -35.59 mV, and encapsulation efficiency of 38.08 ± 15.94%. The antioxidant activity of NLC-Ethyl acetate fraction of moringa leaves increased compared to the IC50 of the ethyl acetate fraction, becoming 71.76 ± 0.81 µg/mL. The NLC-Ethyl acetate fraction formulation showed stability at temperatures of 2-8? for 14 days.